News
"We are excited to be entering into this collaboration with Synfini to accelerate drug discovery around a publicly available high-value target,” said Helena Mancebo, CEO of Multispan. "By using ...
It will highlight critical quality attributes (CQAs) of CAR-T-cell therapies such as identity, potency and ... spans from assay development to validation of cell-based assays.
Orionis Biosciences, a privately held, clinical-stage life sciences company focused on the rational discovery and development of drug modalities with induced proximity mode of action, today announced ...
14h
AZoLifeSciences on MSNNatural Deep Eutectic Solvents Enhance Yield and Antibacterial Activity of Zanthoxylum bungeanumNADES treatments significantly boost essential oil yield and antibacterial activity in Zanthoxylum bungeanum, offering a ...
Invivyd plans to advance next generation COVID-19 mAbs to improve product scalability and system-friendliness while preserving strong anticipated mAb preventative efficacy; additional data on ...
They achieve this by specifically targeting tumour cells and not the healthy cells ... The next big challenge for CMC is how to establish the potency assay. These are normally used to ...
A highly sensitive real-time PCR-based systems helps scientists rapidly detect microbial contamination in cell therapy ...
Researchers from BITS Pilani Hyderabad Campus have claimed to have developed a plant-based therapeutic formulation ... with Thalassemia and Sickle cell Anaemia who depend on frequent blood ...
Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...
Future Virology. 2014;9(8):753-767. CHF: Congestive heart failure; CLD: Chronic lung disease; F: Fusion; G: Glyco; GLA-SE: Glucopyranosyl lipid A-stable emulsion; GMT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results